Gyre Therapeutics Inc (GYRE)
14.15
-1.14
(-7.46%)
USD |
NASDAQ |
May 17, 16:00
14.15
0.00 (0.00%)
After-Hours: 20:00
Gyre Therapeutics Shareholders Equity (Quarterly): 56.64M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 56.64M |
| Date | Value |
|---|---|
| March 31, 2023 | 96.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
56.64M
Minimum
Mar 2024
96.29M
Maximum
Mar 2023
76.47M
Average
76.47M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.01M |
| Total Liabilities (Quarterly) | 33.24M |
| Current Ratio | 3.219 |